2
Announcements
Trials
Browse
Landscape
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
5
Polycythemia Vera
4
Lung Neoplasms
4
Ovarian Neoplasms
3
Myeloproliferative Disorders
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Lymphoma
2
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Adenocarcinoma
2
Urticaria
1
Tuberous Sclerosis
1
Thymic aplasia
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Severe Combined Immunodeficiency
1
Sarcoma
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Rectal Neoplasms
1
Primary Dysautonomias
1
Polycythemia
1
Polycystic Ovary Syndrome
1
Pancreatitis, Chronic
1
Interventions
Mycophenolic Acid
2
Blood Specimen Collection
2
vedolizumab
1
bavituximab
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
Steroids
1
Spermine Synthase
1
Sorafenib
1
Sofosbuvir
1
Ribavirin
1
Prednisone
1
Photopheresis
1
Phlebotomy
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Methoxsalen
1
Liquid Biopsy
1
Infliximab
1
Clinical Protocols
1
Azathioprine
1
Adrenal Cortex Hormones
1
3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hepatitis
×
Phlebotomy
×
Clear all
NCT04306939
2026-01-07
GREAT1
University of Pittsburgh
Suspended
120,000 enrolled